Compare
HeartCore Enterprises, Inc. vs Datacentrex, Inc. vs BioScience Health Innovations, Inc. vs Paranovus Entertainment Technology Ltd.
| Latest fiscal year | HeartCore Enterprises, Inc. HTCR | Datacentrex, Inc. DTCX | BioScience Health Innovations, Inc. BHIC | Paranovus Entertainment Technology Ltd. PAVS |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2026-03-31 |
| Revenue | $8.97M | $6.96M | $5.69M | $14.60M |
| Revenue growth (YoY) | -60.5% | n/a | +208.3% | n/m |
| Gross margin | 35.1% | 48.9% | 57.0% | 16.5% |
| Operating margin | -34.8% | -113.7% | 12.6% | -100.4% |
| Net margin | 64.6% | -122.1% | 11.3% | -87.2% |
| Net income | $5.79M | -$8.50M | $642.1K | -$12.73M |
| EPS (Diluted) | $0.22 | -$0.46 | $0.06 | -$8485.00 |
| Operating cash flow | -$3.12M | -$6.45M | $172.2K | -$1.40M |
| Free cash flow | n/a | -$32.39M | n/a | -$1.40M |
| Cash & equivalents | $1.99M | $38.92M | $661.9K | $10.30M |
| Total assets | $13.06M | $66.84M | $1.71M | $36.87M |
| Total liabilities | $5.78M | n/a | $229.9K | $3.86M |
| Shareholders' equity | $8.78M | $66.25M | $1.48M | $31.25M |
| Return on year-end equity | 66.0% | -12.8% | 43.5% | -40.8% |
| Shares outstanding | 25.42M | 30.38M | 10.98M | n/a |
Revenue, most recent five fiscal years
| Fiscal year | HeartCore Enterprises, Inc. | Datacentrex, Inc. | BioScience Health Innovations, Inc. | Paranovus Entertainment Technology Ltd. |
|---|---|---|---|---|
| Latest | $8.97M Ended 2025-12-31 | $6.96M Ended 2025-12-31 | $5.69M Ended 2025-12-31 | $14.60M Ended 2026-03-31 |
| 1 year earlier | $22.69M Ended 2024-12-31 | $741 Ended 2024-12-31 | $1.84M Ended 2024-12-31 | $71.5K Ended 2025-03-31 |
| 2 years earlier | $21.85M Ended 2023-12-31 | $2.0K Ended 2023-12-31 | $597.6K Ended 2023-12-31 | $0 Ended 2024-03-31 |
| 3 years earlier | $8.82M Ended 2022-12-31 | $2.4K Ended 2022-12-31 | $69.3K Ended 2022-12-31 | $0 Ended 2023-03-31 |
| 4 years earlier | $10.82M Ended 2021-12-31 | $2.4K Ended 2021-12-31 | n/a | $20.76M Ended 2022-03-31 |